Diagnostics, Typing And Identification

A national quality assurance survey of Neisseria gonorrhoeae testing

  • 1Queensland Paediatric Infectious Diseases Laboratory, Queensland Children’s Health Services, Queensland, Australia
  • 2Queensland Children’s Medical Research Institute, University of Queensland, Queensland, Australia
  • 3WHO Collaborating Centre for STD, Microbiology Department, South Eastern Area Laboratory Services, Prince of Wales Hospital, Sydney, New South Wales, Australia
  • 4Microbiological Diagnostic Unit Public Health Laboratory, Department of Microbiology and Immunology, University of Melbourne, Parkville, Victoria, Australia
  • 5Microbiology Laboratory, Pathology Department, Royal Darwin Hospital, Darwin, Northern Territory, Australia
  • 6Microbiology and Infectious Diseases Department, Women's and Children's Hospital, North Adelaide, South Australia, Australia
  • 7PathWest Laboratory Medicine-WA, Royal Perth Hospital, Perth, Western Australia, Australia
  • 8Public Health Microbiology, Communicable Disease, Queensland Health Forensic and Scientific Services, Archerfield, Queensland, Australia
  • 9Microbiology Division, Pathology Queensland Central, Royal Brisbane and Women’s Hospital Campus, Queensland, Australia
  • Correspondence
    David M. Whiley d.whiley{at}uq.edu.au
  • Journal of Medical Microbiology 2014; 63(Pt 1):45–49 · https://doi.org/10.1099/jmm.0.065094-0

    View at publisher PubMed

    Abstract

    The aims of this study were to (1) conduct a national survey of Neisseria gonorrhoeae identification by National Neisseria Network (NNN) reference laboratories contributing data to the Australian Gonococcal Surveillance Programme and (2) determine the prevalence in Australia of strains of N. gonorrhoeae lacking gene sequences commonly targeted by in-house PCR assays for confirmation of gonococcal nucleic acid amplification tests. Gonococcal clinical isolates referred to NNN laboratories for the first half of 2012 were screened using in-house real-time PCR assays targeting multicopy opa, porA pseudogene and cppB genes. There were 2455 clinical gonococcal isolates received in the study period; 98.6 % (2420/2455) of isolates harboured all three gene targets, 0.12 % (3/2455) were porA-negative, 0.04 % (1/2455) opa-negative and 1.14 % (28/2455) cppB-negative by PCR. Notably, no isolates were simultaneously negative for two targets. However, three isolates failed to be amplified by all three PCR methods, one isolate of which was shown to be a commensal Neisseria strain by 16S rRNA sequencing. Using PCR as the reference standard the results showed that (1) identification of N. gonorrhoeae isolates by NNN laboratories was highly specific (99.96 %) and (2) strains of N. gonorrhoeae lacking gene sequences commonly targeted by in-house PCR assays are present but not widespread throughout Australia at this point in time.

    Abbreviations:
    AGSP
    Australia Gonococcal Surveillance Programme
    AMR
    antimicrobial resistance
    NAAT
    nucleic acid amplification test
    NNN
    National Neisseria Network
    QPID
    Queensland Paediatric Infectious Diseases
    NSW
    New South Wales
    NT
    Northern Territory
    Qld
    Queensland
    SA
    South Australia
    Vic
    Victoria
    WA
    Western Australia